Sodium Laural Sulfate

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

45 competitors in Gingivitis

#DrugCompanyPhaseTrials

1

Flagyl

DDePuy Orthopaedics

Approved

32

Peridex

DDexcel Pharma Technologies Ltd.

Approved

23

Cetylpyridinium Chloride

Sanofi

Approved

14

Tea Tree Oil

FFederal University of São Paulo

Approved

15

Triclosan

CColgate Palmolive

Phase 3

16

Active Comparator

Moderna

Phase 2

17

Negative Control

GSK

Phase 3

18

Test

RRespirent Pharmaceuticals Co Ltd.

Phase 2

29

Deltavit

HHyundai Pharmaceutical Co., LTD.

Phase 1

—10

Sodium Laural Sulfate

GSK

Phase 3

1Show 10 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Dentinal Hypersensitivity5 trials

The Efficacy of a Dentifrice in Providing Relief From the Pain of Dentinal Hypersensitivity

Completed·GSK·Phase 3·NCT01592864·120 enrolled

Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity

Completed·GSK·Phase 3·NCT01827670·119 enrolled

Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity

Completed·GSK·Phase 3·NCT01592851·113 enrolled

Show 2 more trials

The Efficacy of a Dentifrice in Providing Relief From Immediate and Short Term Relief From Dentinal Hypersensitivity

Completed·GSK·Phase 3·NCT03072719·120 enrolled

Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity

Completed·GSK·Phase 3·NCT02832375·242 enrolled

Dental Plaque1 trial

Investigation of Dental Plaque and Gingival Index

Completed·CColgate Palmolive·Phase 3·NCT00759031·19 enrolled

Gingivitis1 trial

A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride

Completed·GSK·Phase 3·NCT04123665·98 enrolled

Fluoride1 trial

Potential of Stannous Fluoride Toothpaste to Reduce Gum Disease

Completed·GSK·N/A·NCT02750943·253 enrolled

CAR1 trial

Anti-caries Potential of a Sodium Monofluorophosphate and Calcium Sodium Phosphosilicate Dentifrice

Completed·GSK·Phase 2·NCT01657877·100 enrolled

2 more indications

Irritation1 trial

A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers

Completed·GSK·Phase 1·NCT01112787·39 enrolled

Unspecified1 trial

Evaluation of a Test Mouthwash and Dentifrice Regimen in an In-situ Model of Dental Erosion

Completed·GSK·Phase 2·NCT01128972·36 enrolled

Details

Drug Info

Related News